[{"internal_id": 157818741, "Award ID": "U18DP006747", "Award Amount": 1052207.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2023-03-22", "CFDA Number": "93.068", "Description": "DP22-001 REAL-WORLD EFFECTIVENESS OF STRUCTURED LIFESTYLE INTERVENTIONS IN PREVENTING TYPE 2 DIABETES - 2022", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d4ce585-e95e-2593-758c-86dc120820ad-C", "generated_internal_id": "ASST_NON_U18DP006747_7523"}, {"internal_id": 150291980, "Award ID": "U18DP006712", "Award Amount": 1140000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-07", "CFDA Number": "93.068", "Description": "REAL-WORLD EFFECTIVENESS OF STRUCTURED LIFESTYLE INTERVENTIONS IN PREVENTING TYPE 2 DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_U18DP006712_7523"}, {"internal_id": 150291741, "Award ID": "U18DP006711", "Award Amount": 87792.07, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-07", "CFDA Number": "93.068", "Description": "ASSESSING BARRIERS AND FACILITATORS FOR PARTICIPATING STRUCTURED LIFESTYLE INTERVENTION AND ITS REAL-WORLD EFFECTIVENESS AND COST-EFFECTIVENESS AMONG US VETERANS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "369ac1e4-8d93-3063-b933-3586dffba549-C", "generated_internal_id": "ASST_NON_U18DP006711_7523"}, {"internal_id": 150291483, "Award ID": "U18DP006709", "Award Amount": 1139139.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-02", "CFDA Number": "93.068", "Description": "A SENTINEL NETWORK FOR EVALUATION OF THE REACH, IMPLEMENTATION, EFFECTIVENESS, AND COSTS OF EVIDENCE-BASED LIFESTYLE INTERVENTIONS TO PREVENT TYPE 2 DIABETES IN U.S. ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "89c1b286-4842-cf79-9563-7ec2e987f771-C", "generated_internal_id": "ASST_NON_U18DP006709_7523"}, {"internal_id": 150291743, "Award ID": "U18DP006708", "Award Amount": 1140000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-02", "CFDA Number": "93.068", "Description": "EVALUATING REAL-WORLD DIABETES PREVENTION PROGRAMS IN A MULTI-CAMPUS UNIVERSITY SYSTEM AND A THREE-STATE REGIONAL HEALTH NETWORK", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3231cda5-201a-6da0-de9e-e9810a848983-C", "generated_internal_id": "ASST_NON_U18DP006708_7523"}, {"internal_id": 150292013, "Award ID": "U18DP006707", "Award Amount": 699949.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-01", "CFDA Number": "93.068", "Description": "COORDINATING CENTER (CC) FOR DETERMINING THE LONG-TERM EFFECTIVENESS OF REAL WORLD STRUCTURED LIFESTYLE INTERVENTIONS IN PREVENTING TYPE 2 DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8303ed9b-9fb4-3e90-ca81-50bbcf400948-C", "generated_internal_id": "ASST_NON_U18DP006707_7523"}, {"internal_id": 50097536, "Award ID": "U18DP006289", "Award Amount": 2082924.2, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-30", "CFDA Number": "93.068", "Description": "STUDY TO ASSESS THE INCIDENCE OF TYPE 1 DIABETES IN YOUNG ADULTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d192652e-3551-3991-1674-6885c846fff2-C", "generated_internal_id": "ASST_NON_U18DP006289_7523"}, {"internal_id": 161647689, "Award ID": "U01DP006758", "Award Amount": 750000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2023-07-24", "CFDA Number": "93.068", "Description": "RFA-DP-23-001, SIMULATION MODEL OF INTERVENTIONS LINKING EVIDENCE TO SDOH (SMILES)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8303ed9b-9fb4-3e90-ca81-50bbcf400948-C", "generated_internal_id": "ASST_NON_U01DP006758_7523"}, {"internal_id": 150291990, "Award ID": "U01DP006703", "Award Amount": 1800000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-13", "CFDA Number": "93.068", "Description": "EPIDEMIOLOGY OF LUPUS: LONGITUDINAL STUDIES IN POPULATION-BASED COHORTS - 2022", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "30ebe932-79d5-1659-51b4-a59d9be01dee-C", "generated_internal_id": "ASST_NON_U01DP006703_7523"}, {"internal_id": 150291984, "Award ID": "U01DP006702", "Award Amount": 1757692.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-16", "CFDA Number": "93.068", "Description": "EPIDEMIOLOGY OF LUPUS: LONGITUDINAL STUDIES IN POPULATION-BASED COHORTS - 2022", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "105d3de4-6fbf-6e42-7259-4c62267aa84f-C", "generated_internal_id": "ASST_NON_U01DP006702_7523"}, {"internal_id": 150291998, "Award ID": "U01DP006701", "Award Amount": 1760000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-14", "CFDA Number": "93.068", "Description": "RACIAL/ETHNIC AND SOCIOECONOMIC DISPARITIES IN BIOLOGIC AND CLINICAL SLE OUTCOMES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bb8d1cd4-e0ae-6348-a07c-04df6a112768-C", "generated_internal_id": "ASST_NON_U01DP006701_7523"}, {"internal_id": 150291475, "Award ID": "U01DP006700", "Award Amount": 1799998.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-14", "CFDA Number": "93.068", "Description": "HEALTH: HARNESSING EPIDEMIOLOGY TO ADVANCE LUPUS TREATMENT AND HEALTH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c07787b9-15d4-d1eb-4f0c-2e0b30320bfb-C", "generated_internal_id": "ASST_NON_U01DP006700_7523"}, {"internal_id": 150745567, "Award ID": "U01DP006698", "Award Amount": 1800000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-07-21", "CFDA Number": "93.068", "Description": "GEORGIANS ORGANIZED AGAINST LUPUS: THE GOAL OF BETTER UNDERSTANDING SOCIAL DETERMINANTS OF HEALTH IN LUPUS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d4ce585-e95e-2593-758c-86dc120820ad-C", "generated_internal_id": "ASST_NON_U01DP006698_7523"}, {"internal_id": 138797248, "Award ID": "U01DP006643", "Award Amount": 2999999.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-07-16", "CFDA Number": "93.068", "Description": "NYC CANCER OUTREACH NETWORK IN NEIGHBORHOODS FOR EQUITY AND COMMUNITY TRANSLATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c07787b9-15d4-d1eb-4f0c-2e0b30320bfb-C", "generated_internal_id": "ASST_NON_U01DP006643_7523"}, {"internal_id": 138797371, "Award ID": "U01DP006639", "Award Amount": 2978463.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-07-16", "CFDA Number": "93.068", "Description": "SCALING SOCIAL DETERMINANTS OF HEALTH SCREENING, SOCIAL SUPPORT AND ANTI-RACISM TRAINING TO REDUCE INEQUITIES IN MINORITY CANCER SURVIVOR HEALTH AND WELLBEING IN WASHINGTON, DC", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0ce035ae-709c-ca0b-f9ef-95a8c219bc5f-C", "generated_internal_id": "ASST_NON_U01DP006639_7523"}, {"internal_id": 138797347, "Award ID": "U01DP006636", "Award Amount": 3000000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2021-07-16", "CFDA Number": "93.068", "Description": "REDUCING CANCER DISPARITIES WITHIN THE BLACK COMMUNITY IN JACKSON, MS THROUGH COMMUNITY-LED TOBACCO-RELATED SOCIAL NORM CHANGE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cd387d4c-7c14-396c-35bf-fa1d16b8f085-C", "generated_internal_id": "ASST_NON_U01DP006636_7523"}, {"internal_id": 89523419, "Award ID": "U01DP006444", "Award Amount": 2719237.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2019-08-23", "CFDA Number": "93.068", "Description": "RESEARCH TO ENHANCE THE US VISION AND EYE HEALTH SURVEILLANCE SYSTEM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5e7406f6-85c5-7077-5ebb-789745b75e2d-C", "generated_internal_id": "ASST_NON_U01DP006444_7523"}, {"internal_id": 50093797, "Award ID": "U01DP006327", "Award Amount": 985243.59, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-08-08", "CFDA Number": "93.068", "Description": "VALIDATION OF SURVEY QUESTIONS TO DISTINGUISH TYPE 1 AND TYPE 2 DIABETES AMONG ADULTS WITH DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1a05eb77-da74-5790-7cc1-11f261fd252e-C", "generated_internal_id": "ASST_NON_U01DP006327_7523"}, {"internal_id": 50093796, "Award ID": "U01DP006302", "Award Amount": 3605709.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.068", "Description": "PRIORITIZING COUNTY-LEVEL SOCIAL DETERMINANTS THAT CONTRIBUTE TO THE GREATER BURDEN OF DIABETES AND HYPERTENSION IN THE US", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "385a79b6-b810-9612-774a-ef5d04895c34-C", "generated_internal_id": "ASST_NON_U01DP006302_7523"}, {"internal_id": 50093795, "Award ID": "U01DP006299", "Award Amount": 4081071.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.068", "Description": "COMPONENT A: IMPACT OF COMMUNITY FACTORS ON GEOGRAPHIC DISPARITIES IN DIABETES AND OBESITY NATIONWIDE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c07787b9-15d4-d1eb-4f0c-2e0b30320bfb-C", "generated_internal_id": "ASST_NON_U01DP006299_7523"}, {"internal_id": 50093794, "Award ID": "U01DP006296", "Award Amount": 3794965.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.068", "Description": "COMPONENT A: A MULTI-LEVEL STUDY OF COMMUNITY CONTEXT AND TYPE 2 DIABETES AND CORONARY HEART DISEASE USING ELECTRONIC HEALTH RECORD AND NEW PRIMARY DATA ACROSS NESTED GEOGRAPHIES IN PENNSYLVANIA", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dd31c3bf-fabc-df0b-5ae3-c7fbf71e680e-C", "generated_internal_id": "ASST_NON_U01DP006296_7523"}, {"internal_id": 50093793, "Award ID": "U01DP006293", "Award Amount": 3146259.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2017-09-08", "CFDA Number": "93.068", "Description": "COMPONENT B: COORDINATING CENTER FOR COMMUNITY CHARACTERISTICS ASSOCIATED WITH GEOGRAPHIC DISPARITIES IN DIABETES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "867850a1-1693-4b2a-3ff5-034554d322e1-C", "generated_internal_id": "ASST_NON_U01DP006293_7523"}, {"internal_id": 50093736, "Award ID": "U01DP006093", "Award Amount": 2613540.18, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-24", "CFDA Number": "93.068", "Description": "RAPID ACCESS TO PERINATAL PSYCHIATRIC CARE IN DEPRESSION PROGRAM (RAPPID): AN INNOVATIVE STEPPED-CARE APPROACH FOR OBSTETRICS AND GYNECOLOGY CLINICS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "68a12c06-0ac5-9595-eda2-d8647ffda5d0-C", "generated_internal_id": "ASST_NON_U01DP006093_7523"}, {"internal_id": 50093735, "Award ID": "U01DP006089", "Award Amount": 853422.01, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-02", "CFDA Number": "93.068", "Description": "RENYC. RARE EPILEPSIES IN NEW YORK CITY: EPIDEMIOLOGY AND HEALTH OUTCOMES. IMPROVING SURVEILLANCE WITH TEXT PROCESSING OF CLINICAL NOTES IN ELECTRONI", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "2aebf6db-d015-0e5d-4b7c-d63b5d36ebce-C", "generated_internal_id": "ASST_NON_U01DP006089_7523"}, {"internal_id": 50093733, "Award ID": "U01DP006074", "Award Amount": 3994573.59, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-11", "CFDA Number": "93.068", "Description": "ESTABLISH A VISION AND EYE HEALTH SURVEILLANCE SYSTEM FOR THE NATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5e7406f6-85c5-7077-5ebb-789745b75e2d-C", "generated_internal_id": "ASST_NON_U01DP006074_7523"}, {"internal_id": 151145015, "Award ID": "R44DP006495", "Award Amount": 1730748.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-10", "CFDA Number": "93.068", "Description": "A MOBILE APP BASED COGNITIVE DISSONANCE INTERVENTION FOR SMOKING CESSATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "95c5fe6c-ee09-e6bd-7018-01c96e0beeea-C", "generated_internal_id": "ASST_NON_R44DP006495_7523"}, {"internal_id": 150746017, "Award ID": "R43DP006743", "Award Amount": 259475.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-21", "CFDA Number": "93.068", "Description": "DEVELOPMENT, FEASIBILITY, AND ACCEPTABILITY OF AIM TO PLAY, A USER-FRIENDLY DIGITAL APPLICATION FOR TEACHER SKILLS TRAINING AND PHYSICAL EDUCATION ACTIVITIES FOR 3-5 GRADE ELEMENTARY STUDENTS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "35588b71-cfeb-cf2a-0c08-709b8ab9c092-R", "generated_internal_id": "ASST_NON_R43DP006743_7523"}, {"internal_id": 150291997, "Award ID": "R43DP006691", "Award Amount": 243500.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2022-07-18", "CFDA Number": "93.068", "Description": "HORMONAL CONTRACEPTIVE ACCESS VIA PHARMACIST-PRESCRIBING IMPLEMENTATION PACKAGE (HAPPI)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53112f44-be4b-64a6-a22c-a024d33a55bf-R", "generated_internal_id": "ASST_NON_R43DP006691_7523"}, {"internal_id": 139197872, "Award ID": "R43DP006690", "Award Amount": 243459.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-08-13", "CFDA Number": "93.068", "Description": "ART PROVIDER AND PATIENT RESOURCE TO IMPROVE COMMUNICATION ABOUT OUTCOMES AND TREATMENT (APRICOT)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "18a1d77c-196c-ded4-b89d-ea78f0d2fb01-C", "generated_internal_id": "ASST_NON_R43DP006690_7523"}, {"internal_id": 151589608, "Award ID": "R43CE003534", "Award Amount": 301062.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2022-08-12", "CFDA Number": "93.068", "Description": "PA-20-260, PHS 2020 OMNIBUS SOLICITATION (PARENT SBIR [R43/R44] CLINICAL TRIAL NOT ALLOWED.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "95c5fe6c-ee09-e6bd-7018-01c96e0beeea-C", "generated_internal_id": "ASST_NON_R43CE003534_7523"}, {"internal_id": 49796666, "Award ID": "R21DP006082", "Award Amount": 1195617.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-30", "CFDA Number": "93.068", "Description": "PRENATAL SUBSTANCE USE SCREENING: VALIDATION AND COMPARISON OF PROMISING MEASURES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1882697f-2df0-529a-ed60-116702c184a7-C", "generated_internal_id": "ASST_NON_R21DP006082_7523"}, {"internal_id": 150292052, "Award ID": "NU58DP007190", "Award Amount": 2400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2022-06-24", "CFDA Number": "93.068", "Description": "IMPROVING AND ENHANCING THE US VISION AND EYE HEALTH SURVEILLANCE SYSTEM - SINCE 2015, NORC AND CDC HAVE ESTABLISHED AND ENHANCED THE VISION AND EYE HEALTH SURVEILLANCE SYSTEM (VEHSS). VEHSS CREATES AND PRESENTS SURVEILLANCE INFORMATION USING SECONDARY DATA SOURCES, INCLUDING NATIONALLY REPRESENTATIVE SURVEYS, ADMINISTRATIVE PAYMENT CLAIMS, ELECTRONIC HEALTH RECORDS (EHRS), AND COMPOSITE ESTIMATES FOR HIGH IMPORTANCE CONDITIONS. TODAY, VEHSS IS THE LARGEST REPOSITORY OF VISION AND EYE HEALTH PREVALENCE INFORMATION GLOBALLY, PROVIDING PUBLIC ACCESS TO 246 INDICATORS OF VISION IMPAIRMENT AND BLINDNESS, EYE HEALTH CONDITIONS, AND SERVICE UTILIZATION MEASURED ACROSS 11 DATA SOURCES.  THE NEXT THREE YEARS PROVIDE THE OPPORTUNITY TO CONTINUE TO ENHANCE AND IMPROVE VEHSS THROUGH 1.\tINCREASING THE SYSTEM'S SOCIAL DETERMINANTS OF HEALTH (SDOH) AND COMORBIDITY INFORMATION, 2.\tADDING DATA FROM POPULATIONS NOT INCLUDED IN VEHSS, 3.\tIMPROVING THE VEHSS WEBSITE'S ACCESSIBILITY AND USABILITY, 4.\tSTREAMLINING VEHSS INDICATORS, 5.\tMAINTAINING AND ADDING ADDITIONAL YEARS OF DATA FOR EXISTING VEHSS INDICATORS, AND 6.\tPUBLISHING VEHSS RESULTS AND PROMOTING THEIR AVAILABILITY TO THE PUBLIC.  WE OFFER SOLUTIONS FOR EACH OF THESE OPPORTUNITIES.  NORC PROVIDES IMMEDIATE ACCESS TO NEW DATA FROM THE VETERAN'S HEALTH ADMINISTRATION, MEDICARE ADVANTAGE, THE NATIONAL HEALTH AND AGING TRENDS STUDY, UNINTERRUPTED ACCESS TO CURRENT VEHSS DATA SOURCES AND MODELS, AND THE ANALYSIS CODE AND EXPERTISE TO PUT THESE DATA SOURCES TO WORK. WE ADDITIONALLY PROVIDE A FRAMEWORK FOR EVALUATING NEW SOURCES OF SDOH AND EHR DATA FOR INCLUSION AND PROVIDE OPTIONS TO INCLUDE DATA FROM THE INDIAN HEALTH SERVICE.  HELPING USERS FIND THE INFORMATION THEY NEED IS A PRIMARY CHALLENGE FOR VEHSS. THE SCHEDULED VEHSS 3.0 (FALL 2022 RELEASE) UPDATE PARTIALLY ADDRESSES THIS CHALLENGE BY REORGANIZING VEHSS INDICATORS BY CONDITION INSTEAD OF DATA SOURCE AND VASTLY IMPROVING INDICATOR SEARCH AND SITE NAVIGATION. WE WILL DEVOTE THE NEXT THREE YEARS TO ADDITIONAL STEPS TO ADD DATA DISCOVERY AND VISUALIZATION FEATURES AND IMPROVE THE VEHSS 3.0 ARCHITECTURE AND CONTENT. WE PROPOSE A HEALTHY PEOPLE 2030 DASHBOARD TO PROVIDE QUICK ACCESS TO THE NATION'S VISUAL HEALTH PERFORMANCE MEASURES AND SDOH VISUALIZATION SOLUTIONS. WE WILL REVIEW AND REVISE WEBSITE TEXT AND CONTENT TO INCREASE READABILITY, STREAMLINE VEHSS INDICATORS USING OBJECTIVE CRITERIA, AND IDENTIFY SURVEILLANCE GAPS AND IMPORTANT NEW INDICATORS.  NORC'S DISSEMINATION PLAN INCLUDES PUBLICATIONS, LAY-PERSON SUMMARIES, VIDEOS, WEBINARS, PRESENTATIONS, AND AMPLIFICATION BY OUR PARTNERS USING THEIR SOCIAL MEDIA CHANNELS AND EMAIL LISTS. WE PROPOSE USING ADOBE ANALYTICS REPORTS MORE AGGRESSIVELY TO IDENTIFY THE VEHSS INFORMATION THAT IS MOST OFTEN ACCESSED AND USE THIS INFORMATION TO INFORM OUR DISSEMINATION PRODUCTS.  NORC'S STAFF AND COLLABORATIVE PARTNERS OFFER CDC UNMATCHED EXPERIENCE WITH THE VEHSS SYSTEM AND CONTENT AREA KNOWLEDGE IN VISION AND EYE HEALTH, CHRONIC DISEASE SURVEILLANCE, BIOSTATISTICS, EPIDEMIOLOGY, COMMUNICATIONS, INFORMATICS, DATA VISUALIZATION, AND IMPLEMENTING CREATIVE WEB DEVELOPMENT SOLUTIONS WITHIN THE AGENCY-WIDE SECURITY AND ACCESSIBILITY CONSTRAINTS OF THE CDC.GOV WEBSITE. WE PROVIDE AN ARTICULATED WORK PLAN THAT DESCRIBES EXACTLY WHEN EACH STEP OF THE PROJECT WILL OCCUR AND A DETAILED EVALUATION PLAN LINKING PROJECT ACTIVITIES TO THEIR PERFORMANCE MEASURES. WE HAVE SUCCESSFULLY ESTABLISHED, MAINTAINED, AND ENHANCED VEHSS OVER THE LAST SEVEN YEARS AND CAN CONTINUE TO DO SO OVER THE NEXT THREE YEARS. NORC PROVIDES CDC WITH A PARTNER THAT ENSURES UNINTERRUPTED MAINTENANCE OF VEHSS AND CAN INVEST THE NEXT THREE YEARS TOWARDS CONTINUED IMPROVEMENT AND ENHANCEMENTS RATHER THAN RE-BUILDING.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5e7406f6-85c5-7077-5ebb-789745b75e2d-C", "generated_internal_id": "ASST_NON_NU58DP007190_7523"}, {"internal_id": 110026097, "Award ID": "NU58DP006908", "Award Amount": 6287803.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-08-25", "CFDA Number": "93.068", "Description": "DEVELOPING AND DISSEMINATING PROGRAMS TO BUILD SUSTAINABLE LUPUS AWARENESS, KNOWLEDGE, SKILLS AND PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "107cfdd4-abc2-0832-c72a-dd99b054f503-C", "generated_internal_id": "ASST_NON_NU58DP006908_7523"}, {"internal_id": 110025877, "Award ID": "NU58DP006907", "Award Amount": 6266481.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2020-08-24", "CFDA Number": "93.068", "Description": "PARTNERS UNITED FOR LUPUS SUSTAINABLE EDUCATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b385315b-97aa-96b5-81f9-c8141316ce3c-C", "generated_internal_id": "ASST_NON_NU58DP006907_7523"}, {"internal_id": 49215104, "Award ID": "NU58DP006262", "Award Amount": 3695634.3, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-09", "CFDA Number": "93.068", "Description": "ADVANCING ARTHRITIS PUBLIC HEALTH APPROACHES THROUGH NATIONAL ORGANIZATIONS: EXPANDING AND SUSTAINING THE DISSEMINATION AND DELIVERY OF AAEBIS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f371179b-9f27-8013-f81c-4fd314b1f981-C", "generated_internal_id": "ASST_NON_NU58DP006262_7523"}, {"internal_id": 49215103, "Award ID": "NU58DP006261", "Award Amount": 1934182.85, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-09", "CFDA Number": "93.068", "Description": "ADVANCING ARTHRITIS PUBLIC HEALTH APPROACHES THROUGH NATIONAL ORGANIZATIONS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f3ba9de2-ec25-bd9c-c722-8f9fefcd473c-C", "generated_internal_id": "ASST_NON_NU58DP006261_7523"}, {"internal_id": 49215102, "Award ID": "NU58DP006260", "Award Amount": 1979109.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-09", "CFDA Number": "93.068", "Description": "INNOVATIVE DISSEMINATION AND DELIVERY SYSTEMS THROUGH LOCAL PARKS AND RECREATION", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "744e544c-f8ec-3293-2529-2737668cc6dc-C", "generated_internal_id": "ASST_NON_NU58DP006260_7523"}, {"internal_id": 49215101, "Award ID": "NU58DP006259", "Award Amount": 2142395.49, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-09", "CFDA Number": "93.068", "Description": "YMCA OF THE USA - ADVANCING ARTHRITIS PUBLIC HEALTH APPROACHES", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f725d461-b59e-3ea4-dcaa-7292226bee36-C", "generated_internal_id": "ASST_NON_NU58DP006259_7523"}, {"internal_id": 49215100, "Award ID": "NU58DP006258", "Award Amount": 748291.5, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-09", "CFDA Number": "93.068", "Description": "HELPLINE PROJECT", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b7f3d019-e1ff-f898-e6e2-1ff1e33159ae-C", "generated_internal_id": "ASST_NON_NU58DP006258_7523"}, {"internal_id": 49215090, "Award ID": "NU58DP006139", "Award Amount": 5681565.42, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-15", "CFDA Number": "93.068", "Description": "PARTNERS UNITED FOR LUPUS SUSTAINABLE EDUCATION (PULSE)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b385315b-97aa-96b5-81f9-c8141316ce3c-C", "generated_internal_id": "ASST_NON_NU58DP006139_7523"}, {"internal_id": 49215089, "Award ID": "NU58DP006138", "Award Amount": 6183246.96, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-09-15", "CFDA Number": "93.068", "Description": "PROGRAM TO BUILD SUSTAINABLE LUPUS AWARENESS, KNOWLEDGE, SKILLS, AND PARTNERSHIPS", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "107cfdd4-abc2-0832-c72a-dd99b054f503-C", "generated_internal_id": "ASST_NON_NU58DP006138_7523"}, {"internal_id": 49214469, "Award ID": "NU58DP003836", "Award Amount": 400000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-10", "CFDA Number": "93.068", "Description": "ESTABLISHING A SURVEILLANCE SYSTEM FOR CHRONIC KIDNEY DISEASE-COMPONENT 1", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_NU58DP003836_7523"}, {"internal_id": 49214468, "Award ID": "NU58DP003835", "Award Amount": 200000.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-08-10", "CFDA Number": "93.068", "Description": "ESTABLISHING A SURVEILLANCE SYSTEM FOR CHRONIC KIDNEY DISEASE-COMPONENT 2", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "1567efcf-bcdb-61b9-72f2-70cbed5fa626-C", "generated_internal_id": "ASST_NON_NU58DP003835_7523"}, {"internal_id": 49214465, "Award ID": "NU58DP003828", "Award Amount": 164536.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-30", "CFDA Number": "93.068", "Description": "NATIONAL ARTHRITIS POLICY PLATFORM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b7f3d019-e1ff-f898-e6e2-1ff1e33159ae-C", "generated_internal_id": "ASST_NON_NU58DP003828_7523"}, {"internal_id": 49214464, "Award ID": "NU58DP003824", "Award Amount": 440063.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-30", "CFDA Number": "93.068", "Description": "NACDD PARTNERSHIPS TO CREATE AND IMPLEMENT A NATIONAL ARTHRITIS POLICY PLATFORM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f3ba9de2-ec25-bd9c-c722-8f9fefcd473c-C", "generated_internal_id": "ASST_NON_NU58DP003824_7523"}, {"internal_id": 49214463, "Award ID": "NU58DP003806", "Award Amount": 43671.0, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2015-07-30", "CFDA Number": "93.068", "Description": "MANAGEMENT AND DISSEMINATION OF EVIDENCE-BASED ARTHRITIS INTERVENTIONS AND CONSUM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b7f3d019-e1ff-f898-e6e2-1ff1e33159ae-C", "generated_internal_id": "ASST_NON_NU58DP003806_7523"}, {"internal_id": 49214436, "Award ID": "NU58DP001006", "Award Amount": 749025.16, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-19", "CFDA Number": "93.068", "Description": "COLORADO PROJECT TO PROMOTE POPULATION HEALTH THROUGH INCREASED CAPACITY IN ALCOHOL EPIDEMIOLOGY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c744e75b-6c82-8490-fac2-35b735f965e2-C", "generated_internal_id": "ASST_NON_NU58DP001006_7523"}, {"internal_id": 49214435, "Award ID": "NU58DP001005", "Award Amount": 684745.85, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-19", "CFDA Number": "93.068", "Description": "PROMOTING POPULATION HEALTH THROUGH INCREASED CAPACITY IN ALCOHOL EPIDEMIOLOGY IN UTAH", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ad190718-78aa-6598-2e74-432b73a2d3f5-C", "generated_internal_id": "ASST_NON_NU58DP001005_7523"}, {"internal_id": 49214434, "Award ID": "NU58DP001004", "Award Amount": 744273.54, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-19", "CFDA Number": "93.068", "Description": "ALCOHOL DOES A NUMBER ON MINNESOTA: PROMOTING HEALTH EQUITY FOR ALL MINNESOTANS THROUGH INCREASED CAPACITY IN ALCOHOL EPIDEMIOLOGY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ea379b9d-a912-39d6-b055-40bc266557f2-C", "generated_internal_id": "ASST_NON_NU58DP001004_7523"}, {"internal_id": 49214433, "Award ID": "NU58DP001003", "Award Amount": 701259.71, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-19", "CFDA Number": "93.068", "Description": "THE MICHIGAN ALCOHOL EPIDEMIOLOGY PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4d57e46-9637-11ab-7bec-0b42644bb57c-C", "generated_internal_id": "ASST_NON_NU58DP001003_7523"}, {"internal_id": 49214432, "Award ID": "NU58DP001002", "Award Amount": 646373.12, "Award Type": "COOPERATIVE AGREEMENT (B)", "Base Obligation Date": "2016-08-19", "CFDA Number": "93.068", "Description": "NEW MEXICO DEPARTMENT OF HEALTH PROPOSAL FOR PROMOTING POPULATION HEALTH THROUGH INCREASED CAPACITY IN ALCOHOL EPIDEMIOLOGY", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8ba15d07-8e80-311c-14d2-386306377f2c-C", "generated_internal_id": "ASST_NON_NU58DP001002_7523"}]